High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
- PMID: 18509183
- DOI: 10.1200/JCO.2007.15.6521
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
Erratum in
- J Clin Oncol. 2008 Jul 20;26(21):3659
- J Clin Oncol. 2013 Aug 20;31(24):3049
Abstract
Purpose: To investigate prognostic values of the intratumoral and peritumoral expression of macrophage colony-stimulating factors (M-CSF) in hepatocellular carcinoma (HCC) patients after curative resection.
Patients and methods: Expression of M-CSF and density of macrophages (M Phi) were assessed by immunohistochemistry in tissue microarrays containing paired tumor and peritumoral liver tissue from 105 patients who had undergone hepatectomy for histologically proven HCC. Prognostic value of these and other clinicopathologic factors was evaluated.
Results: Neither intratumoral M-CSF nor M Phi density was associated with overall survival (OS) or disease-free survival (DFS). High peritumoral M-CSF and M Phi density, which correlated with large tumor size, presence of intrahepatic metastasis, and high TNM stage, were independent prognostic factors for both OS (P = .001 and P < .001, respectively) and DFS (P = .001 and P = .003, respectively) and affected incidence of early recurrence. In a small HCC subset, peritumoral M-CSF was also correlated with both OS and DFS (P = .038 and P = .001, respectively). The combination of peritumoral M-CSF and M Phi had a better power to predict the patients' death and disease recurrence (P < .001 for both).
Conclusion: High peritumoral M-CSF and M Phi were associated with HCC progression, disease recurrence, and poor survival after hepatectomy, highlighting the importance of peritumoral tissue in the recurrence and metastasis of HCC. M-CSF and M Phi may be targets of postoperative adjuvant therapy.
Similar articles
-
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.Oncologist. 2010;15(7):732-43. doi: 10.1634/theoncologist.2009-0170. Epub 2010 Jun 15. Oncologist. 2010. PMID: 20551429 Free PMC article.
-
Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.Mol Biol Rep. 2012 May;39(5):6001-6. doi: 10.1007/s11033-011-1413-y. Epub 2011 Dec 29. Mol Biol Rep. 2012. PMID: 22205539
-
Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.World J Gastroenterol. 2016 Oct 21;22(39):8779-8789. doi: 10.3748/wjg.v22.i39.8779. World J Gastroenterol. 2016. PMID: 27818593 Free PMC article.
-
Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.Ann Surg Oncol. 2014 Apr;21(4):1304-13. doi: 10.1245/s10434-013-3445-0. Epub 2013 Dec 24. Ann Surg Oncol. 2014. PMID: 24366422 Clinical Trial.
-
The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis.Pathol Res Pract. 2023 Dec;252:154919. doi: 10.1016/j.prp.2023.154919. Epub 2023 Nov 4. Pathol Res Pract. 2023. PMID: 37939428 Review.
Cited by
-
Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.Tumour Biol. 2013 Apr;34(2):669-74. doi: 10.1007/s13277-012-0594-x. Epub 2012 Nov 23. Tumour Biol. 2013. PMID: 23179403
-
Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.J Neurooncol. 2021 Jun;153(2):225-237. doi: 10.1007/s11060-021-03767-x. Epub 2021 May 8. J Neurooncol. 2021. PMID: 33963961 Free PMC article.
-
Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.Tumour Biol. 2016 Sep;37(9):12635-12642. doi: 10.1007/s13277-016-5175-y. Epub 2016 Jul 21. Tumour Biol. 2016. PMID: 27444274
-
Translational medicine in hepatocellular carcinoma.Front Med. 2012 Jun;6(2):122-33. doi: 10.1007/s11684-012-0193-7. Epub 2012 May 9. Front Med. 2012. PMID: 22573220 Review.
-
The Role of Tumor Epithelial-Mesenchymal Transition and Macrophage Crosstalk in Cancer Progression.Curr Osteoporos Rep. 2023 Apr;21(2):117-127. doi: 10.1007/s11914-023-00780-z. Epub 2023 Feb 27. Curr Osteoporos Rep. 2023. PMID: 36848026 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials